US gives conditional nod to Zoetis' bird flu vaccine for poultry
The U.S. Department of Agriculture has given a conditional approval to Zoetis to use its bird flu vaccine in poultry, the animal healthcare company said on Friday.
Mass.-based Moderna could be first to manufacture bird flu vaccine
A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find humans as hospitable hosts.
The US Has Bird Flu Vaccines. Here’s Why You Can’t Get One
H5N1 vaccines have been previously licensed, and millions are in the national stockpile. But even with the news of the country’s first human death due to bird flu, vaccination isn’t yet recommended.
Bird Flu: US Invests $590 Million to Fast-Track Vaccine Development
The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.
Zoetis Gets Conditional License From USDA for Bird Flu Vaccine
Zoetis said the U.S. Department of Agriculture's Center for Veterinary Biologics issued the company a conditional license for its Avian Influenza Vaccine, H5N2 Subtype, Killed Virus. The vaccine is labeled for use in chickens,
Zoetis Receives Conditional License from USDA for Avian Influenza Vaccine, H5N2 Subtype, Killed Virus
Zoetis today announced that the U.S. Department of Agriculture (USDA), Center for Veterinary Biologics (CVB) has issued the company a conditional license for its Avian Influenza Vaccine, H5N2 Subtype,
What to know about bird flu in 2025, according to a public health expert
How does bird flu spread? Can people get bird flu? Bird flu can infect birds as well as mammals, including pigs, cattle and ...
Moderna awarded $590M to help accelerate development of mRNA-based bird flu vaccine: HHS
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.
Moderna Q4 Earnings Preview: COVID-19 Vaccine Sales, Bird Flu Vaccine Candidates On Watch
Moderna, Inc. (NASDAQ:MRNA) is set to release its fourth-quarter earnings on Friday before the opening bell. Here's a look at ...
AOL9d
As bird flu becomes a growing threat, Moderna is awarded $590M to develop mRNA pandemic influenza vaccines
Last year, Moderna completed a Phase I/II clinical trial of an investigational influenza vaccine called mRNA-1018, which was tested against H5 and H7 bird flu subtypes. The company said in a ...
FierceBiotech25d
HHS gives Moderna $590M to 'accelerate' bird flu vaccine trials
The U.S. government has handed Moderna almost $600 million to accelerate its work on various bird flu vaccines as well as work on mRNA vaccines for other influenza strains with pandemic ...
BioPharma Dive11d
Drugmakers prep for bird flu outbreak, despite continued low risk
While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.
Are eggs safe to eat? Kent State expert answers your questions about bird flu
Q&A: From people avoiding wild birds to farmers protecting their animals, Kent State epidemiologist Dr. Tara Smith shares ...
WBAL27d
Moderna awarded $590M to help accelerate development of mRNA-based bird flu vaccine
The U.S. government previously awarded the vaccine manufacturer $176 million in July 2024 to help expedite the development of an mRNA vaccine that could be used for bird flu.
Here is what Lehigh Valley hospitals say they are doing about bird flu
Avian influenza is continuing to plague poultry and dairy farming operations, and with the virus spreading across the country ...